Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00367991Phase 2Completed
Phase 2, randomised, double-blind trial in myocardial infarction (MI) comparing rHuEpo with Placebo (2 arms). Primary endpoints: Bleeding Time and Platelet Function Assay Closure Time. Started Nov 2006; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00367991.